About the Beijing AI Center 

The Beijing AI Center is a new strategic investment by AstraZeneca to accelerate drug discovery through AI. The center brings together AI researchers, computational scientists, and platform engineers to apply foundation models, agentic AI, and large-scale scientific computing to real R&D problems. Situated in one of the world’s most dynamic AI talent markets, it operates at the intersection of biologics discovery, computational chemistry, and AI-driven drug discovery. 

The center is structured around three pillars: Discovery verticals (therapeutic design and preclinical predictions), Data & AI Platforms, and Ecosystem Partnerships with leading Chinese academic institutions and AI companies. This role sits within the Data & AI Platforms pillar, with a mandate to bring the center’s Agentic AI platform to life for China R&D. 

About the Role 

This role owns the Agentic AI platform for AstraZeneca’s China R&D organization...